Ten63 Therapeutics
Until No Patient Is Out of Options
- Headquarters
- Durham, North Carolina
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- ten63tx.com
- Total Funding
- $45.3M
- Last Round
- $29.1M Venture RoundFeb 2026
About
Ten63 Therapeutics is an AI-driven drug discovery company developing therapeutics for previously undruggable targets using its proprietary BEYOND platform. BEYOND fuses quantum simulations with generative chemistry to simulate trillions of potential drug candidates, enabling the company to pursue high-impact targets that are data-poor and experimentally difficult to reach.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account